MTOR and breast carcinoma: A combination of structure-based virtual screening and biochemical analysis led to the finding of a new inhibitor (AM879) for ATAD2 bromodomain, which is able to trigger apoptosis and autophagy in breast cancer cells via PI3K-AKT-mTOR signaling [51].